 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 02, 2022 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced today that the Company will hold a conference call and webcast on March 14, 2022, at 9:00 a.m. EST to review fourth quarter and full-year 2021 financial results and provide a corporate update. 